SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-003882
Filing Date
2019-01-07
Accepted
2019-01-07 17:01:06
Documents
3
Period of Report
2019-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d685603d8k.htm 8-K 20799
2 EX-99.1 d685603dex991.htm EX-99.1 16567
3 EX-99.2 d685603dex992.htm EX-99.2 15820
  Complete submission text file 0001193125-19-003882.txt   54464
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 19513919
SIC: 2834 Pharmaceutical Preparations